Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$84.55 - $115.06 $9,300 - $12,656
-110 Reduced 29.49%
263 $28,000
Q3 2023

Feb 15, 2024

SELL
$104.28 - $143.36 $11,470 - $15,769
-110 Reduced 29.49%
263 $28,000
Q2 2023

Feb 15, 2024

SELL
$125.33 - $184.35 $7,394 - $10,876
-59 Reduced 13.66%
373 $48,000
Q2 2023

Jul 28, 2023

SELL
$125.33 - $184.35 $7,394 - $10,876
-59 Reduced 13.66%
373 $48,000
Q3 2022

Feb 15, 2024

BUY
$139.58 - $214.98 $23,589 - $36,331
169 Added 64.26%
432 $61,000
Q2 2022

Feb 14, 2024

BUY
$182.13 - $260.0 $30,779 - $43,940
169 Added 64.26%
432 $88,000
Q2 2022

Jul 26, 2022

BUY
$182.13 - $260.0 $78,680 - $112,320
432 New
432 $88,000

Others Institutions Holding MLAB

About MESA LABORATORIES INC


  • Ticker MLAB
  • Exchange NASDAQ
  • Sector Technology
  • Industry Scientific & Technical Instruments
  • Shares Outstandng 5,317,270
  • Market Cap $704M
  • Description
  • Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the ...
More about MLAB
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.